BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34120511)

  • 21. Spindle cell sarcoma with
    Fujikawa T; Uemura S; Yoshida M; Hyodo S; Kozaki A; Saito A; Kishimoto K; Ishida T; Mori T; Uematsu A; Morita K; Hatakeyama T; Tamura A; Yamamoto N; Komatsu M; Soejima T; Hasegawa D; Kosaka Y
    Oncol Lett; 2022 Dec; 24(6):452. PubMed ID: 36380878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel BRAF gene fusions and activating point mutations in spindle cell sarcomas with histologic overlap with infantile fibrosarcoma.
    Penning AJ; Al-Ibraheemi A; Michal M; Larsen BT; Cho SJ; Lockwood CM; Paulson VA; Liu YJ; Plank L; Fritchie K; Beadling C; Neff TL; Corless CL; Rudzinski ER; Davis JL
    Mod Pathol; 2021 Aug; 34(8):1530-1540. PubMed ID: 33850302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma.
    Knezevich SR; McFadden DE; Tao W; Lim JF; Sorensen PH
    Nat Genet; 1998 Feb; 18(2):184-7. PubMed ID: 9462753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel gene fusions in secretory carcinoma of the salivary glands: enlarging the ETV6 family.
    Guilmette J; Dias-Santagata D; Nosé V; Lennerz JK; Sadow PM
    Hum Pathol; 2019 Jan; 83():50-58. PubMed ID: 30130630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infantile fibrosarcoma-like tumor driven by novel
    Gupta A; Belsky JA; Schieffer KM; Leraas K; Varga E; McGrath SD; Koo SC; Magrini V; Wilson RK; White P; Mardis ER; Jatana KR; Cottrell CE; Setty BA
    Cold Spring Harb Mol Case Stud; 2020 Oct; 6(5):. PubMed ID: 33028644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel ETV6-NTRK3 gene fusion in primary renal fibrosarcoma.
    Jiang H
    Eur Rev Med Pharmacol Sci; 2022 Jul; 26(13):4705-4708. PubMed ID: 35856362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myxoid spindle cell sarcoma with ETV6-NTRK3 fusion.
    Kyriazoglou A; Dimitriadis E; Mahaira L; Kotsantis J; Kouloulias V; Kontogeorgakos V; Psyrri A; Agrogiannis G
    Cancer Genet; 2022 Nov; 268-269():93-96. PubMed ID: 36274330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.
    Prasad ML; Vyas M; Horne MJ; Virk RK; Morotti R; Liu Z; Tallini G; Nikiforova MN; Christison-Lagay ER; Udelsman R; Dinauer CA; Nikiforov YE
    Cancer; 2016 Apr; 122(7):1097-107. PubMed ID: 26784937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Congenital mesoblastic nephroma: a study of 19 cases using immunohistochemistry and ETV6-NTRK3 fusion gene rearrangement.
    El Demellawy D; Cundiff CA; Nasr A; Ozolek JA; Elawabdeh N; Caltharp SA; Masoudian P; Sullivan KJ; de Nanassy J; Shehata BM
    Pathology; 2016 Jan; 48(1):47-50. PubMed ID: 27020209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mammary Analogue Secretory Carcinoma of Salivary Glands: Molecular Analysis of 25 ETV6 Gene Rearranged Tumors With Lack of Detection of Classical ETV6-NTRK3 Fusion Transcript by Standard RT-PCR: Report of 4 Cases Harboring ETV6-X Gene Fusion.
    Skálová A; Vanecek T; Simpson RH; Laco J; Majewska H; Baneckova M; Steiner P; Michal M
    Am J Surg Pathol; 2016 Jan; 40(1):3-13. PubMed ID: 26492182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathologic and Molecular Characterization of Four Cases of Pediatric Salivary Secretory Carcinoma (SSC), One with ETV6-RET Fusion.
    Salgado CM; Alaggio R; Reyes-Múgica M; Zin A; de Vito R
    Head Neck Pathol; 2021 Sep; 15(3):796-802. PubMed ID: 33459993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infantile NTRK-associated Mesenchymal Tumors.
    Davis JL; Lockwood CM; Albert CM; Tsuchiya K; Hawkins DS; Rudzinski ER
    Pediatr Dev Pathol; 2018; 21(1):68-78. PubMed ID: 28683589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants.
    Wegert J; Vokuhl C; Collord G; Del Castillo Velasco-Herrera M; Farndon SJ; Guzzo C; Jorgensen M; Anderson J; Slater O; Duncan C; Bausenwein S; Streitenberger H; Ziegler B; Furtwängler R; Graf N; Stratton MR; Campbell PJ; Jones DT; Koelsche C; Pfister SM; Mifsud W; Sebire N; Sparber-Sauer M; Koscielniak E; Rosenwald A; Gessler M; Behjati S
    Nat Commun; 2018 Jun; 9(1):2378. PubMed ID: 29915264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a novel PHIP::BRAF gene fusion in infantile fibrosarcoma.
    Boulouadnine B; de Villenfagne L; Galant C; Sciot R; Brichard B; Demoulin JB
    Genes Chromosomes Cancer; 2022 Nov; 61(11):678-682. PubMed ID: 35672277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infantile fibrosarcoma of thigh--a case report.
    Himori K; Hatori M; Watanabe M; Moriya T; Ogose A; Hashimoto H; Kokubun S
    Ups J Med Sci; 2005; 110(1):85-93. PubMed ID: 15801689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells.
    Wai DH; Knezevich SR; Lucas T; Jansen B; Kay RJ; Sorensen PH
    Oncogene; 2000 Feb; 19(7):906-15. PubMed ID: 10702799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Case of Congenital Infantile Fibrosarcoma of the Bowel Presenting as a Neonatal Intussusception.
    Obayashi J; Koizumi H; Hoshikawa M; Wakisaka M; Fujikawa A; Kitagawa H; Takagi M
    Pathol Int; 2017 Dec; 67(12):644-648. PubMed ID: 29090505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion.
    Bielack SS; Cox MC; Nathrath M; Apel K; Blattmann C; Holl T; Jenewein R; Klenk U; Klothaki P; Müller-Abt P; Ortega-Lawerenz S; Reynolds M; Scheer M; Simon-Klingenstein K; Stegmaier S; Tupper R; Vokuhl C; von Kalle T
    Ann Oncol; 2019 Nov; 30(Suppl_8):viii31-viii35. PubMed ID: 31738425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion.
    Bielack SS; Cox MC; Nathrath M; Apel K; Blattmann C; Holl T; Jenewein R; Klenk U; Klothaki P; Müller-Abt P; Ortega-Lawerenz S; Reynolds M; Scheer M; Simon-Klingenstein K; Stegmaier S; Tupper R; Vokuhl C; von Kalle T
    Ann Oncol; 2019 Nov; 30 Suppl 8():viii31-viii35. PubMed ID: 32223937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours.
    Yamamoto H; Yoshida A; Taguchi K; Kohashi K; Hatanaka Y; Yamashita A; Mori D; Oda Y
    Histopathology; 2016 Jul; 69(1):72-83. PubMed ID: 26647767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.